INTERLEUKIN-6 FUNCTIONS AS AN INTRACELLULAR GROWTH-FACTOR IN HAIRY-CELL LEUKEMIA IN-VITRO

被引:46
作者
BARUT, B
CHAUHAN, D
UCHIYAMA, H
ANDERSON, KC
机构
[1] HARVARD UNIV, SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL, 44 BINNEY ST, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
B-CELL MALIGNANCY; TUMOR NECROSIS FACTOR; INTERLEUKIN-6 ANTISENSE OLIGONUCLEOTIDE; IL-6; RECEPTORS; AUTOCRINE GROWTH FACTOR;
D O I
10.1172/JCI116839
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of interleukin-6 (IL-6) in the growth of B cell derived hairy cell leukemia (HCL) was characterized. Purified hairy cells (HCs) did not increase DNA synthesis in vitro in response to exogenous IL-6; however, they expressed IL-6 receptor (IL-6R) mRNA and bound directly fluorochrome labeled IL-6. IL-6 mRNA was not detectable in tumor cells by Northern blotting, but was evident using PCR amplification. Although intracytoplasmic IL-6 protein was not demonstrable, HCs did secrete low levels of IL-6. Neutralizing antibody to IL-6 did not inhibit HC DNA synthesis. Since tumor necrosis factor (TNF) is a growth factor for HCL, we determined whether the TNF effect could be IL-6-mediated. TNF markedly augmented in vitro DNA synthesis by HCs. TNF did not alter IL-6R expression or IL-6 binding; however, IL-6 mRNA and IL-6 protein were detectable after 3-d culture of HCs with TNF. In addition, IL-6 secretion by HCs was markedly augmented by TNF. Finally, although neither IL-6 nor anti-IL-6 antibody altered TNF-induced DNA synthesis by HCs, IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion by HCs. Therefore, IL-6 does not directly affect the growth of HCL, but rather mediates TNF-induced DNA synthesis via an intracytoplasmic mechanism.
引用
收藏
页码:2346 / 2352
页数:7
相关论文
共 66 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]  
ANDERSON KC, 1985, BLOOD, V65, P620
[3]  
ANDERSON KC, 1989, BLOOD, V73, P1915
[4]  
ANDERSON KC, 1983, J IMMUNOL, V130, P1132
[5]   ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J].
BARUT, BA ;
ZON, LI ;
COCHRAN, MK ;
PAUL, SR ;
CHAUHAN, D ;
MOHRBACHER, A ;
FINGEROTH, J ;
ANDERSON, KC .
LEUKEMIA RESEARCH, 1992, 16 (10) :951-959
[6]  
BARUT BA, 1990, BLOOD, V76, P2091
[7]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011
[8]   TRANSFORMATION BY V-SIS OCCURS BY AN INTERNAL AUTOACTIVATION MECHANISM [J].
BEJCEK, BE ;
LI, DY ;
DEUEL, TF .
SCIENCE, 1989, 245 (4925) :1496-1499
[9]  
BERGAMASCHI G, 1991, LEUKEMIA, V5, P886
[10]  
BILLARD C, 1990, J IMMUNOL, V145, P1713